glp-1 blood pressure Receptor Agonists and Pressure: A State-of-the-Art Review of Mechanisms, Evidence, and Clinical Implications Frontiers | The benefits of
Description
In 2014, the FDA and the EMA found no causal association between GLP-1RA and pancreatic adverse events (67)

But in most cases, weve seen that patients exclusively seeking weight loss usually need higher doses of the same drug

Allergic Reactions It is crucial to distinguish between allodynia (nerve sensitivity) and a true allergic reaction

This conclusion is based on studies where laboratory animals given semaglutide, liraglutide, tirzepatide and other GLP-1 medications developed tumors

Understanding when to resume semaglutide after surgery helps plan the post-operative timeline

Li D, Yang JY, Wang T, et al
